EFG Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.16M Sell
14,973
-48,556
-76% -$5.95M 0.28% 140
2025
Q2
$6.39M Sell
63,529
-30,696
-33% -$2.35M 0.9% 20
2025
Q1
$7.18M Sell
94,225
-13,400
-12% -$1.03M 1.19% 11
2024
Q4
$7.43M Buy
107,625
+56,758
+112% +$4.09M 1.01% 13
2024
Q3
$3.71M Sell
50,867
-3,031
-6% -$224K 0.62% 39
2024
Q2
$3.61M Sell
53,898
-18,640
-26% -$723K 0.63% 41
2024
Q1
$1.97M Buy
72,538
+12,814
+21% +$359K 0.34% 124
2023
Q4
$1.85M Buy
59,724
+7,031
+13% +$182K 0.35% 109
2023
Q3
$1.33M Sell
52,693
-5,031
-9% -$115K 0.32% 116
2023
Q2
$1.22M Sell
57,724
-3,416
-6% -$64.8K 0.26% 130
2023
Q1
$1.04M Sell
61,140
-3,423
-5% -$66.5K 0.23% 147
2022
Q4
$1.29M Buy
64,563
+16,317
+34% +$315K 0.29% 125
2022
Q3
$1.04M Sell
48,246
-46,484
-49% -$1.11M 0.24% 137
2022
Q2
$1.87M Sell
94,730
-8,128
-8% -$170K 0.39% 81
2022
Q1
$2.42M Sell
102,858
-918
-0.9% -$21.3K 0.36% 85
2021
Q4
$2.83M Buy
+103,776
New +$2.97M 0.37% 77

Other funds holding INSM

EFG Asset Management's INSM Position: Q3 2025 in Review

EFG Asset Management reduced its Insmed (INSM) stake by 76% in Q3 2025, selling an estimated $5.95M and leaving 14,973 shares worth $2.16M. The position accounts for 0.28% of the portfolio, ranked #140.

EFG Asset Management first reported a position in INSM in Q4 2021 and has held it in 16 quarters since. The position peaked at $7.43M in Q4 2024. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • EFG Asset Management held 14,973 shares of Insmed worth $2.16M as of Q3 2025.
  • EFG Asset Management sold 48,556 Insmed shares in Q3 2025, an estimated $5.95M.
  • Insmed made up 0.28% of EFG Asset Management's portfolio in Q3 2025, its #140 holding.
  • EFG Asset Management first reported a position in Insmed in Q4 2021 and has held it in 16 quarters since.
  • EFG Asset Management's Insmed position peaked at $7.43M in Q4 2024.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.